Keros Therapeutics Shares Are Trading Higher After the Company Announced It Closed Screening for Its Phase 2 Clinical TROPOS Trial.
Keros Therapeutics Shares Are Trading Higher After the Company Announced It Closed Screening for Its Phase 2 Clinical TROPOS Trial.
keros therapeutics股票交易上漲，此前公司宣佈完成了其2期臨床試驗TROPOS的篩選工作。
Keros Therapeutics Shares Are Trading Higher After the Company Announced It Closed Screening for Its Phase 2 Clinical TROPOS Trial.
keros therapeutics股票交易上漲，此前公司宣佈完成了其2期臨床試驗TROPOS的篩選工作。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。